SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SEC STAFF LETTER - SEC Staff Letter: REDACTED EXHIBIT
SEC Accession No. 9999999997-19-005627
Filing Date
2019-06-18
Accepted
2019-06-19 10:01:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REDACTED EXHIBIT 102124
  Complete submission text file 9999999997-19-005627.txt   141674
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SEC STAFF
SIC: 2836 Biological Products, (No Diagnostic Substances)